Biotech News
Related news
HYPRHyperfine2026-08-06 20:05 EST
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results
HYPRHyperfine2026-10-08 11:30 EST
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million
XTNTXtant Medical2026-08-06 12:00 EST
Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026
MMSIMerit Medical2026-10-06 20:30 EST
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
IARTIntegra LifeSciences2026-10-06 12:30 EST
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026
ANGOAngioDynamics2026-10-08 10:02 EST
AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability
IRIXIRIDEX2026-08-18 20:05 EST
Iridex Reports Second Quarter 2026 Financial Results
STIMNeuronetics2026-08-11 11:50 EST
Neuronetics Reports Second Quarter 2026 Financial and Operating Results
TCMDTactile Systems Technology, Inc.2026-08-10 20:05 EST
Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results
TMCITreace Medical Concepts2026-08-07 11:05 EST
Treace Medical Concepts Reports Second Quarter 2026 Financial Results
Hyperfine
Portable Brain MRI Company Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure. Low-Field Imaging Platform Swoop uses low-field magnetic resonance and can be moved through hospitals, reducing the logistical burden of...
Recent company news
HYPRHyperfine2026-10-08 11:30 EST
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026
HYPRHyperfine2026-10-08 11:30 EST
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million
HYPRHyperfine2026-09-28 12:15 EST
Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets
HYPRHyperfine2026-09-15 12:15 EST
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
HYPRHyperfine2026-08-31 12:15 EST
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference
Stock data
- Close
- 0.87 USD
- Market cap
- 148.91M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States